Medtronic

Medtronic's reported carbon emissions

Medtronic, headquartered in the US, has demonstrated a commitment to climate action through its emissions reporting and reduction targets. In 2025, the company reported a total of approximately 5.50 billion kg CO2e. This figure is comprised of Scope 1 emissions of about 174 million kg CO2e, Scope 2 emissions of approximately 79 million kg CO2e, and substantial Scope 3 emissions totalling about 5.27 billion kg CO2e. Key contributors to Medtronic's Scope 3 emissions in 2025 included purchased goods and services (approximately 3.65 billion kg CO2e), upstream transportation and distribution (about 461 million kg CO2e), and end-of-life treatment of sold products (around 302 million kg CO2e). Medtronic has set ambitious climate goals, including a commitment to achieve net zero across all scopes by 2050. This long-term target is supported by nearer-term goals, such as a commitment to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 52% by FY2030 from a FY2020 base year. Furthermore, the company aims to source 100% renewable electricity by FY2030. In line with its Scope 3 reduction efforts, Medtronic is targeting a 37.5% reduction in absolute Scope 3 emissions from upstream transportation and distribution, business travel, and end-of-life treatment of sold products by FY2034, based on a FY2024 baseline. The company is also working to ensure that 75% of its suppliers by emissions, covering purchased goods and services and capital goods, will have science-based targets by FY2030.